Drugs / AG-858
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00058747 | Mar 2003 → Apr 2006 | chronic myeloid leukemia | Agenus Inc. | Terminated | No outcome recorded Stop: Business |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AG-858 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00058747 ↗ |